Baptist Medical Center 111 Dallas Street, San Antonio, TX 78205
University Health System 4502 Medical Drive, San Antonio, TX 78229
University of Texas Health Center at Tyler 11937 Us Highway 271, Tyler, TX 75708
Education:
Medical School Yale University School Of Medicine Graduated: 1986 Medical School University Of California San Francisco Graduated: 1987 Medical School University Of California San Francisco Graduated: 1989 Medical School National Canc Institute Graduated: 1993 Medical School Usuhs Graduated: 1996
Michael R. Landauer - Bethesda MD, US Thomas Michael Seed - Bethesda MD, US Venkataraman Srinivasan - Germantown MD, US Alla Shapiro - Rockville MD, US Chris H. Takimoto - Boerne TX, US
Assignee:
The United States of America as represented by the Secretary Department of Health and Human Services - Washington DC Henry M. Jackson Foundation for the Advancement of Military Medicine - Rockville MD
International Classification:
A61K 31/35 A01N 43/16
US Classification:
514456, 514460
Abstract:
The present invention provides compositions and methods for the prophylactic and therapeutic treatment of animals, including humans from radiation injury. In particular, the present invention provides methods and compositions comprising the isoflavone genistein (4′,5,7-trihydroxyflavone) or phytoestrogenic isoflavonoids.
Phytoestrogenic Isoflavone Compositions, Their Preparation And Use Therof For Protection Against And Treatment Of Radiation Injury
Michael Landauer - Bethesda MD, US Thomas Seed - Bethesda MD, US Venkataraman Srinivasan - Germantown MD, US Alla Shapiro - Rockville MD, US Chris Takimoto - Boerne TX, US
International Classification:
C09K003/00 E02D003/00
US Classification:
252/001000, 405/258100
Abstract:
The present invention provides compositions and methods for the prophylactic and therapeutic treatment of animals, including humans from radiation injury. In particular, the present invention provides methods and compositions comprising the isoflavone genistein (4′, 5, 7-trihydroxyfllavone) or phytoestrogenic isoflavonoids.
Gilead Sciences
Senior Vice President
Forty Seven, Inc.
Chief Medical Officer
The Janssen Pharmaceutical Companies of Johnson & Johnson Sep 2010 - Jan 2016
Vice President, Experimental Medicine Early Development, Oncology Therapeutic Area
Ortho Biotech Oncology R&D/Johnson & Johnson Apr 2008 - Sep 2010
Senior Director, Translational Medicine
Start- South Texas Accelerated Research Therapeutics Jul 2007 - Apr 2008
Director of Pharmacology
Education:
Uniformed Services University of the Health Sciences 1994 - 1996
National Cancer Institute 1990 - 1993
University of California, San Francisco 1986 - 1989
Yale University 1979 - 1986
Doctorates, Doctor of Philosophy, Pharmacology
Yale University School of Medicine 1979 - 1986
Doctor of Medicine, Doctorates, Medicine
Stanford University 1975 - 1979
Bachelors, Bachelor of Science, Chemistry
Skills:
Drug Development Clinical Development Clinical Research Translational Medicine Pharmacology Cancer Translational Research Biotechnology Clinical Pharmacology Pharmaceutical Industry Biomarkers Hematology Pharmacokinetics Pharmacodynamics Oncology Drug Development